Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

Isavuconazole (ISA) is a triazole antifungal agent recommended for treatment of invasive aspergillosis or mucormycosis. The objective of this study was to evaluate ISA levels in a real world setting in a mixed patient cohort including patients with non-malignant diseases and extracorporeal treatment...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Christoph Zurl, Maximilian Waller, Franz Schwameis, Tina Muhr, Norbert Bauer, Ines Zollner-Schwetz, Thomas Valentin, Andreas Meinitzer, Elisabeth Ullrich, Stefanie Wunsch, Martin Hoenigl, Yvonne Grinschgl, Juergen Prattes, Abderrahim Oulhaj, Robert Krause
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2020-06-01
Цуврал:	Journal of Fungi
Нөхцлүүд:	isavuconazole fungal infections therapeutic drug monitoring anti-infective agents antifungal therapy
Онлайн хандалт:	https://www.mdpi.com/2309-608X/6/2/90
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!